Skip to main content
Patient and doctor at an appointment.

Frequently asked questions about RHAPSIDO® (remibrutinib)

Patient portrayal.

CSU, chronic spontaneous urticaria.
*Limitations apply. Subject to annual co-pay benefit limit. Offer not valid under Medicare, Medicaid, or any other federal or state programs. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at rhapsido.com for details.